Bullfrog Ai Holdings Inc (BFRG) Stock Price, Quote & News

Company Profile

Bullfrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform to analyze preclinical and clinical data for biotechnology and pharmaceutical companies, and other organizations. It also develops BF-222, a novel formulation of mebendazole , which is in the fir...

Industry: Health Information Services

Sector: Healthcare

Phone: 240 658 6710

Website: www.bullfrogai.com

Address:

325 Ellington Boulevard, Unit 317, Gaithersburg, United States

WeTheMarket Oct. 26 at 10:00 AM

$BFRG Warning: @JuanValdex and @Mastermind1111 (formerly @DummyDave) are the same person (see posts below, and many more, too many to repost here). Who needs impostors, block both @JuanValdex and @Mastermind1111, you'll thank me later.

0 · Reply

Frandy305 Oct. 25 at 11:18 PM

$BFRG Looking like a possible double bottom bullish pattern.

0 · Reply

Bulltrader988 Oct. 25 at 8:42 PM

$BFRG 👃👀 https://finviz.com/quote.ashx?t=BFRG&ty=c&ta=1&p=d

0 · Reply

WeTheMarket Oct. 24 at 9:46 PM

$BFRG SEC Form 8-K filed after market close today on results of Special Meeting of Shareholders. As expected everything passed. https://ir.bullfrogai.com/sec-filings/all-sec-filings/content/0001493152-25-019360/0001493152-25-019360.pdf

0 · Reply

WeTheMarket Oct. 23 at 1:26 PM

$BFRG Investor Webinar with BullFrog AI CEO, Vin Singh, October 30, 2025 4:15 PM ET. Register at https://www.redchip.com/webinar/BFRG/83637822231

1 · Reply

twighttrades1 Oct. 23 at 11:43 AM

$BFRG - waiting til after split to add- no other angle mskes sense as this should bring it to like $1 pre split or lower depending on how the ratio is

1 · Reply

WeTheMarket Oct. 23 at 10:42 AM

$BFRG https://www.linkedin.com/in/antoniomontano/

0 · Reply

WeTheMarket Oct. 23 at 10:27 AM

$BFRG Recent hire, June 2025. https://www.linkedin.com/in/antoniomontano/ Antonio Montano Helping Biotech, Pharma & SaaS Companies Accelerate Growth Through AI, Data-Driven GTM Strategy & Modern Marketing Leadership | Fractional CMO With 19+ years of experience across Life Sciences, Biotech, Bioinformatics, Pharma, and SaaS, I help organizations accelerate growth by designing and executing full-funnel marketing strategies that connect science to sales. As a growth-driven marketing leader, I specialize in building scalable marketing engines that generate demand, increase product adoption, and drive measurable revenue from brand awareness through lead conversion. I specialize in driving growth in life sciences and biotech brands translating complex science into compelling narratives that resonate with scientific, clinical, and technical audiences. By combining AI, data, and strategic insight, I develop full-funnel marketing strategies that don’t just inform, they convert.

2 · Reply

JuanValdex Oct. 23 at 4:11 AM

$BFRG Stock failed because CEO was selling thru a plan. Now CEO gets advice to do a RS. NOW buyers again sit on the fence and boycott the stock bc nobody knows wtf next. CEO has killed another rally attempt. HEY VIN>>> HIRE JUAN FOR SOME CONSULTING....

0 · Reply

WeTheMarket Oct. 22 at 7:25 PM

$BFRG Did not attend but I'm sure everything passed as CEO alone owns almost 30% of outstanding shares. This will be officially documented in an SEC filing after market close today or tomorrow. As a reminder, following is ChatGPT's take on why management structured these proposals: - Pre-approve the Lincoln Park facility: Nasdaq rules require shareholder approval before issuing ≥20% of outstanding stock to certain investors. Getting shareholder approval now avoids the need for additional actions each time shares are sold and enables the company to use the committed facility without procedural obstacles. - Reverse split gives flexibility / market mechanics: A reverse split (1:2 up to 1:15) is a common tool to (a) increase the per-share price (help meet any Nasdaq minimum bid-price concerns), (b) reduce outstanding share count so future issuance represents a smaller percentage of outstanding shares, and (c) make the 20% ceiling under Nasdaq more manageable in dollar/volume terms.

2 · Reply

BullFrog AI's bfPREP™ and bfLEAP® Platforms Deliver Real-World Impact in Eleison Pharmaceuticals Collaboration

Jul 28, 2025, 4:30 PM EDT - 3 months ago

BullFrog AI to Present at BTIG Annual Virtual Biotechnology Conference

Jul 22, 2025, 8:00 AM EDT - 3 months ago

Rethinking R&D: BullFrog AI White Paper Outlines New Blueprint for Smarter Drug Development

Jun 20, 2025, 8:00 AM EDT - 4 months ago

BullFrog AI's Dr. Juan Felipe Beltrán to Highlight Advanced AI Strategies in Bioinformatics at XTalks Webinar

Jun 12, 2025, 8:00 AM EDT - 4 months ago

BullFrog AI Announces Strategic Collaboration with Sygnature Discovery to Introduce BullFrog Data Networks™ to Global Biopharma Clients

Dec 27, 2024, 8:00 AM EST - 10 months ago

BullFrog AI Issues Letter to Stockholders

Dec 17, 2024, 4:30 PM EST - 11 months ago

BullFrog AI Announces Appointment of Chief Financial Officer

Oct 22, 2024, 7:30 AM EDT - 1 year ago

BullFrog AI's VP Artificial Intelligence to Present at Google's Cancer AI Symposium

Oct 21, 2024, 1:00 PM EDT - 1 year ago

WallachBeth Capital Announces Closing of Bullfrog AI Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million

Oct 21, 2024, 11:45 AM EDT - 1 year ago

Bullfrog AI Announces Closing of Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million

Oct 18, 2024, 12:01 PM EDT - 1 year ago

WallachBeth Capital Announce Pricing of Bullfrog AI's Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million

Oct 18, 2024, 9:30 AM EDT - 1 year ago

Bullfrog AI Announces Pricing of Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million

Oct 15, 2024, 7:30 AM EDT - 1 year ago

BullFrog AI Strengthens Scientific Advisory Board with the Addition of GSK Veteran and Industry Pioneer Dr. John Baldoni

Oct 9, 2024, 7:30 AM EDT - 1 year ago

BullFrog AI Announces Publication of Data Supporting Potential of Liver Disease Treatment Candidate BF-114

Sep 24, 2024, 8:51 AM EDT - 1 year ago

Top 4 Health Care Stocks That May Keep You Up At Night

DOCS GILD GNFT

Aug 26, 2024, 8:00 AM EDT - 1 year ago

BullFrog AI to Participate at the H.C. Wainwright 26th Annual Global Investment Conference

Jul 25, 2024, 7:30 AM EDT - 1 year ago

BullFrog AI and Lieber Institute for Brain Development Reveal New Insights into Bipolar Disorder Pathways and Potential Drug Targets

May 29, 2024, 8:00 AM EDT - 1 year ago

Join BullFrog AI's Exclusive Live Investor Webinar and Q&A Session on June 12

May 16, 2024, 8:00 AM EDT - 1 year ago

BullFrog AI and Lieber Institute for Brain Development Collaboration Identifies Novel Drug Targets for Neuropsychiatric Disorders

Apr 26, 2024, 9:00 AM EDT - 1 year ago

BullFrog AI and GreenPower Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Mar 8, 2024, 8:00 AM EST - 1 year ago

BullFrog AI Announces Availability of Fireside Chat Recording Featuring CEOs of BullFrog AI and the Lieber Institute

Feb 21, 2024, 12:01 PM EST - 1 year ago

BullFrog AI Announces Underwriter's Decision to Exercise Over-Allotment Option to Purchase 218,382 Shares of the Company's Common Stock

Feb 9, 2024, 8:00 AM EST - 1 year ago

BullFrog AI to Discuss Findings from its Collaboration with Lieber Institute for Brain Development in Fireside Chat Hosted by RedChip

Feb 5, 2024, 10:15 AM EST - 1 year ago

WallachBeth Capital Announces Closing Of Bullfrog AI $5.7 Million Public Offering

Feb 5, 2024, 10:00 AM EST - 1 year ago

BullFrog AI Announces Closing of $5.7 Million Public Offering

Feb 1, 2024, 9:56 AM EST - 1 year ago

WallachBeth Capital Announces Bullfrog AI Pricing of $5.7 Million Public Offering

Feb 1, 2024, 9:00 AM EST - 1 year ago

Bullfrog AI Announces Pricing of $5.7 Million Public Offering

Jan 26, 2024, 7:30 AM EST - 1 year ago

BullFrog AI Strengthens Scientific Advisory Board with the Addition of Dr. Gwenn Smith and Dr. Jeremiah Wala

Jan 17, 2024, 12:01 PM EST - 1 year ago

This AI stock is up 30% on Wednesday: find out more

Jan 17, 2024, 7:00 AM EST - 1 year ago

BullFrog AI's Collaboration with Lieber Institute for Brain Development Yields Potentially Groundbreaking Biological Stratification of Brain Expression Data

Jan 16, 2024, 8:00 AM EST - 1 year ago

BullFrog AI Announces Issuance of Australian Patent Protecting Novel Prodrugs of Mebendazole and Their Use in Treating Cancer

Jan 11, 2024, 4:05 PM EST - 1 year ago

BullFrog AI to Present at Webull LIVE! Healthcare Webinar on January 17

Dec 29, 2023, 8:00 AM EST - 1 year ago

BullFrog AI Issues Letter to Shareholders

Dec 6, 2023, 7:00 AM EST - 2 years ago

BullFrog AI Launches Preclinical Study to Investigate BF-114's Potential in Battling Obesity

Oct 27, 2023, 9:00 AM EDT - 2 years ago

ASP Isotopes and Bullfrog AI Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV

ASPI

Oct 18, 2023, 9:00 AM EDT - 2 years ago

BullFrog AI to Present at Benzinga All Access Event on October 20

Oct 5, 2023, 8:00 AM EDT - 2 years ago

BullFrog AI Announces Identification of Novel Potential Drug Targets for Colorectal Cancer Using Its AI-Driven bfLEAP™ Platform

Sep 25, 2023, 8:00 AM EDT - 2 years ago

BullFrog AI Founder and CEO Vin Singh to Present Company Overview at BioFuture 2023

Sep 20, 2023, 8:00 AM EDT - 2 years ago

BullFrog AI Announces Launch of BullFrog Data Networks™, a Data Insights Tool Powered by the bfLEAP™ Platform

Sep 14, 2023, 4:30 PM EDT - 2 years ago

BullFrog AI Founder and CEO Vin Singh to Present Company Overview at Maxim Group's Emerging Growth in AI Virtual Tech Conference Series

Sep 13, 2023, 7:01 AM EDT - 2 years ago

BullFrog AI Announces Three-Year Global Strategic Partnership with the Lieber Institute for Brain Development

Sep 7, 2023, 4:05 PM EDT - 2 years ago

BullFrog AI Announces Investor Webinar with CEO and Founder Vin Singh on Thursday, September 14, 2023

Aug 23, 2023, 8:00 AM EDT - 2 years ago

BullFrog AI Technology Licensed from Johns Hopkins University APL Named Finalist in R&D 100 Awards

Aug 2, 2023, 12:45 PM EDT - 2 years ago

RedChip Launches 'Small Stocks, Big Money' Podcast

LTRN RVPH STSS

Jul 25, 2023, 7:30 AM EDT - 2 years ago

BullFrog AI Announces Issuance of U.S. Patent Protecting Novel Prodrugs of Mebendazole and Their Use in Treating Cancer

Jun 9, 2023, 6:30 AM EDT - 2 years ago

BullFrog AI CEO Vin Singh to Present at the Gujarati Physicians Convention 2023

Jun 7, 2023, 6:30 AM EDT - 2 years ago

BullFrog AI Continues to Expand Team with Appointment of New VP of Business Development

Jun 5, 2023, 6:30 AM EDT - 2 years ago

BullFrog AI Strengthens Capabilities of its AI Platform through Expansion of Licensing Agreement with Johns Hopkins Applied Physics Laboratory

May 26, 2023, 4:30 PM EDT - 2 years ago

BullFrog AI Files Quarterly Report on Form 10-Q

May 19, 2023, 9:00 AM EDT - 2 years ago

Sharps Technology, Inc. and BullFrog AI Holdings, Inc. Interviews to Air on Bloomberg TV on the RedChip Money Report(R)

STSS

WeTheMarket Oct. 26 at 10:00 AM

0 · Reply

Frandy305 Oct. 25 at 11:18 PM

$BFRG Looking like a possible double bottom bullish pattern.

0 · Reply

Bulltrader988 Oct. 25 at 8:42 PM

$BFRG 👃👀 https://finviz.com/quote.ashx?t=BFRG&ty=c&ta=1&p=d

0 · Reply

WeTheMarket Oct. 24 at 9:46 PM

0 · Reply

WeTheMarket Oct. 23 at 1:26 PM

$BFRG Investor Webinar with BullFrog AI CEO, Vin Singh, October 30, 2025 4:15 PM ET. Register at https://www.redchip.com/webinar/BFRG/83637822231

1 · Reply

twighttrades1 Oct. 23 at 11:43 AM

$BFRG - waiting til after split to add- no other angle mskes sense as this should bring it to like $1 pre split or lower depending on how the ratio is

1 · Reply

WeTheMarket Oct. 23 at 10:42 AM

$BFRG https://www.linkedin.com/in/antoniomontano/

0 · Reply

WeTheMarket Oct. 23 at 10:27 AM

2 · Reply

JuanValdex Oct. 23 at 4:11 AM

0 · Reply

WeTheMarket Oct. 22 at 7:25 PM

2 · Reply

JuanValdex Oct. 22 at 6:37 PM

$BFRG JIM STEINMAN WAS A GENIUS.... MAYBE WE CAN MAKE MUSIC. https://www.youtube.com/clip/UgkxUyXxG3MEDwtR5_1CbseHoojx3Vt1LLCe https://www.youtube.com/clip/UgkxUyXxG3MEDwtR5_1CbseHoojx3Vt1LLCe

0 · Reply

JuanValdex Oct. 22 at 6:17 PM

$BFRG hey vin. its Juan. I can do whatever i want , Yes you can say that all you want. but i can do whatever i want too. I can be your friend or not.

0 · Reply

JuanValdex Oct. 22 at 6:14 PM

$BFRG HEY VIN, ONLY A 2/1. you can make both sides happy. the people who are followers ( yech) and voted for the RS and the others who voted against by only going 2/1.

0 · Reply

JuanValdex Oct. 22 at 4:50 PM

$BFRG JUAN SAYS HEY VIN ONLY A 2/1 MAX 3/1.

0 · Reply

JuanValdex Oct. 22 at 4:44 PM

$BFRG No new longs.... Do not add. see what this lincoln park is made of.

0 · Reply

JuanValdex Oct. 22 at 3:55 PM

$BFRG SIT ON HANDS AND LET VOLUME DRY-UP. VIN DOESNT GET IT.

0 · Reply

MrBrokeAf Oct. 22 at 3:54 PM

$BFRG Dafuq?

0 · Reply

Hdheheh Oct. 22 at 2:49 PM

$BFRG what happened at the meeting

1 · Reply

JuanValdex Oct. 22 at 2:13 PM

$BFRG NEEDS CLOSES ABOVE 1.44

0 · Reply

Kkamag Oct. 21 at 10:34 PM

$BFRG trash

0 · Reply

Hdheheh Oct. 21 at 1:02 AM

$BFRG investor meeting tomorrow?

0 · Reply

azazelhazel Oct. 19 at 5:49 PM

$VHAI looks like we number one setup this week according to perplexity. $EDGM $RITE $RR $BFRG .

1 · Reply

Market Cap	14.56M
Revenue (ttm)	0.00
Net Income (ttm)	-6.99M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.05

Volume	96,698
Avg Vol	246,082
Day's Range	N/A - N/A
Shares Out	10.25M
Stochastic %K	30%
Beta	0.53
Analysts	Strong Buy
Price Target	N/A